HEMODYNAMIC-EFFECTS OF MEXILETINE

被引:15
作者
SHANKS, RG
机构
关键词
D O I
10.1016/0002-8703(84)90176-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1065 / 1071
页数:7
相关论文
共 29 条
[1]  
ALLEN JD, 1977, POSTGRAD MED J, V53, P35
[2]   EFFECT OF KO 1173, A NEW ANTICONVULSANT AGENT ON EXPERIMENTAL CARDIAC-ARRHYTHMIAS [J].
ALLEN, JD ;
SHANKS, RG ;
ZAIDI, SA ;
KOFIEKUE, JM .
BRITISH JOURNAL OF PHARMACOLOGY, 1972, 45 (04) :561-&
[3]  
BANIM SO, 1977, POSTGRAD MED J, V53, P74
[4]  
CAMPBELL NP, 1973, LANCET, V2, P404
[5]  
CAMPBELL NPS, 1979, BRIT HEART J, V41, P182
[6]  
CAMPBELL NPS, 1977, EUR J CARDIOL, V6, P245
[7]  
CAMPBELL NPS, 1978, BRIT J CLIN PHARMACO, V6, P103, DOI 10.1111/j.1365-2125.1978.tb00833.x
[8]   MEXILETINE IN THE PROPHYLAXIS OF VENTRICULAR ARRHYTHMIAS DURING ACUTE MYOCARDIAL-INFARCTION [J].
CAMPBELL, RWF ;
ACHUFF, SC ;
POTTAGE, A ;
MURRAY, A ;
PRESCOTT, LF ;
JULIAN, DG .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1979, 1 (01) :43-52
[9]   COMPARISON OF PROCAINAMIDE AND MEXILETINE IN PREVENTION OF VENTRICULAR ARRHYTHMIAS AFTER ACUTE MYOCARDIAL-INFARCTION [J].
CAMPBELL, RWF ;
DOLDER, MA ;
PRESCOTT, LF ;
TALBOT, RG ;
MURRAY, A ;
JULIAN, DG .
LANCET, 1975, 1 (7919) :1257-1260
[10]  
CHAMBERLAIN DA, 1980, LANCET, V2, P1324